Highly conserved cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic influenza viruses

Influenza Other Respir Viruses. 2010 Sep;4(5):249-58. doi: 10.1111/j.1750-2659.2010.00161.x.

Abstract

Background: The relatively mild nature of the 2009 influenza pandemic (nH1N1) highlights the overriding importance of pre-existing immune memory. The absence of cross-reactive antibodies to nH1N1 in most individuals suggests that such attenuation may be attributed to pre-existing cellular immune responses to epitopes shared between nH1N1 virus and previously circulating strains of inter-pandemic influenza A viruses.

Results: We sought to identify potential CD4+ T cell epitopes and predict the level of cross-reactivity of responding T cells. By performing large-scale major histocompatibility complex II analyses on Hemagglutinin (HA) proteins, we investigated the degree of T-cell cross-reactivity between seasonal influenza A (sH1N1, H3N2) from 1968 to 2009 and nH1N1 strains. Each epitope was examined against all the protein sequences that correspond to sH1N1, H3N2, and nH1N1. T-cell cross-reactivity was estimated to be 52%, and maximum conservancy was found between sH1N1 and nH1N1 with a significant correlation (P < 0.05).

Conclusions: Given the importance of cellular responses in kinetics of influenza infection in humans, our findings underscore the role of T-cell assays for understanding the inter-pandemic variability in severity and for planning treatment methods for emerging influenza viruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Conserved Sequence*
  • Cross Reactions*
  • Epitopes, T-Lymphocyte / immunology*
  • Hemagglutinins, Viral / immunology*
  • Histocompatibility Antigens Class II / immunology
  • Humans
  • Immunity, Cellular
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza A Virus, H3N2 Subtype / immunology*
  • Influenza, Human / immunology

Substances

  • Epitopes, T-Lymphocyte
  • Hemagglutinins, Viral
  • Histocompatibility Antigens Class II
  • hemagglutinin fusogenic peptide, influenza virus